Although this study is too small to yield general conclusions, some interesting results are evident: (1) atypical nevi may respond to imiquimod cream more or less briskly depending on their level of underlying cellular dysplasia. Such differences may reflect underlying cellular differences between mildl...
A lesson for the clinician. Intraoperative frozen section appearance of persistent basal cell carcinoma after apparent cure with imiquimod 5% cream.doi:10.1111/J.1524-4725.2009.01300.XSean A. SukalMatthew J. MahlbergLori BrightmanDavid R. DanielMedwin M. MintzisRoy G. GeronemusDermatol Surg...
In an open-label study we assessed the response rate and posttreatment follow-up of topical imiquimod 5% cream in 5 patients with basal cell carcinoma (BCC... E Cowen,MG Mercurio,AA Gaspari - 《Journal of the American Academy of Dermatology》 被引量: 68发表: 2002年 Topical imiquimod treatm...
Disseminated Superficial Actinic Porokeratosis on the Face Treated with Imiquimod 5% Cream Porokeratoses are a group of hereditary or acquired disorders characterized by annular lesions with an atrophic center and a prominent peripheral ridge. Pa... H Riad,K Mansour,H Al Sada,... - 《Case Report...
Imiquimod creamInternal MedicineBackground The SINS trial (Controlled Clinical Trials ISRCTN48755084; Eudract No. 2004-004506-24) is a randomised controlled trial evaluating long term success of excisional surgery vs. imiquimod 5% cream for low risk nodular and superficial basal cell carcinoma (BCC)....